Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Medical Developments International

MVP
Current price
0.45 AUD -0.005 AUD (-1.10%)
Last closed 0.46 AUD
ISIN AU000000MVP2
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange Australian Securities Exchange
Capitalization 50 866 493 AUD
Yield for 12 month -41.56 %
1Y
3Y
5Y
10Y
15Y
MVP
21.11.2021 - 28.11.2021

Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers Penthrox, a trauma and emergency pain relief product for use in hospitals, emergency departments, ambulance services, sport medicines, and for analgesia during short procedures. The company also distributes asthma and chronic obstructive pulmonary disease products, such space chambers, peak flow meters, portable nebulisers, and silicon face mask. The company was founded in 1972 and is headquartered in Scoresby, Australia. Address: 4 Caribbean Drive, Scoresby, VIC, Australia, 3179

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

2.44 AUD

P/E ratio

Dividend Yield

Current Year

+33 260 416 AUD

Last Year

+32 445 688 AUD

Current Quarter

+18 127 725 AUD

Last Quarter

+15 132 693 AUD

Current Year

+24 447 897 AUD

Last Year

-2 524 456 AUD

Current Quarter

+2 961 921 AUD

Last Quarter

-5 470 325 AUD

Key Figures MVP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -12 747 702 AUD
Operating Margin TTM -14.6 %
PE Ratio
Return On Assets TTM -11.21 %
PEG Ratio
Return On Equity TTM -64.53 %
Wall Street Target Price 2.44 AUD
Revenue TTM 33 260 417 AUD
Book Value 0.53 AUD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -2.2 %
Dividend Yield
Gross Profit TTM 22 286 656 AUD
Earnings per share -0.46 AUD
Diluted Eps TTM -0.46 AUD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY -84.5 %
Profit Margin -123.66 %

Dividend Analytics MVP

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

307 %

Dividend History MVP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date 05.03.2020
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation MVP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 166.6667
Enterprise Value Revenue 1.3216
Price Sales TTM 1.5293
Enterprise Value EBITDA 278.771
Price Book MRQ 1.1208

Financials MVP

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators MVP

For 52 weeks

0.38 AUD 1.08 AUD
50 Day MA 0.45 AUD
Shares Short Prior Month
200 Day MA 0.52 AUD
Short Ratio
Shares Short
Short Percent